Compounded Tirzepatide
US$ 28.58
compounded tirzepatide discontinued GLP-1 & GIP weekly GLP Compounded vs regular tirzepatide: key
Description
It turns out that, yes, as you may have suspected, lots of people are using GLP-1s
Pemvidutide (ALT-801), a balanced (1:1) GLP-1/glucagon dual receptor agonist, induces rapid and marked weight loss without the need for dose titration in people with overweight/obesity
When you can tolerate your current dose for two weeks with minimal or no GI side effects, you are ready to increase
Many patients notice improved exercise tolerance as cardiovascular health improves
Additionally, concurrent use with other GLP-1 receptor agonists is not recommended due to duplicative therapy
Wang J, Chen Y, Lu Y, Wang H, Zhao Y
